JAMA· 2021Q1

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

Tom T. Shimabukuro, Matt Cole, John R. Su

488citations
Q1SCImago
2021year

Short summary

An analysis of anaphylaxis reports following mRNA COVID-19 vaccination in the US (Dec 14, 2020 - Jan 18, 2021) identified 47 verified cases, with a rate of 2.5 cases per million doses administered.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Immunology and Allergy

Immunology and AllergyMedicine